Ophthalmology 360?

During a session at the American Glaucoma Society Annual Meeting, titled “The Future Starts Now – What’s Next in the Supraciliary Space and Interventional Drug Delivery,” Analisa Arosemena, MD, of the Correct Vision Laser Institute, spoke about the use of travoprost intracameral implant (iDose?) for glaucoma management. Read more: https://lnkd.in/eg7WcbYv #Glaucoma #MIGS #GlaucomaSurgery

Lotilaner ophthalmic solution (0.25%) is a safe and effective treatment for Demodex blepharitis, significantly reducing collarettes, mite density, and erythema over 6 weeks with minimal adverse effects and high patient comfort, according to a pooled analysis of 2 pivotal clinical trials. Read more here: https://lnkd.in/eAE6t_WC #DryEye #DryEyeDisease #DemodexBlepharitis

?? One week to go! I’ll be speaking with Thomas V Johnson at the Glaucoma Congressional Briefing hosted by National Alliance for Eye and Vision Research (NAEVR) in Washington, D.C. As a severe glaucoma patient, I’m honored to share my story and advocate for greater awareness about glaucoma. It is the leading cause of irreversible blindness, affecting over 4 million Americans. ?? Date: March 18th?? Time: 12-1 PM??? Location: Rayburn Room 2045 This event will highlight the critical need for early detection, innovative treatments, and sustained research to reduce healthcare costs and preserve vision for millions. A special thank you to our sponsors—ARVO, AbbVie, Johnson & Johnson, and Théa—for making this event possible. Let’s work together to shine a light on glaucoma and vision research! ?? #GlaucomaAwareness #VisionResearch #PatientAdvocacy #CongressionalBriefing #EyeHealth

Although pseudophakic donor grafts pose greater challenges during preparation and have longer recovery times compared to phakic and scarred stromal grafts, they can still provide comparable outcomes in Descemet membrane endothelial keratoplasty (DMEK) when complications do not occur, according to a study. Read more: https://lnkd.in/g8FPF3Zu #OcularSurface #OrganDonor #NationalEyeDonorMonth

A secondary analysis of data from the Age-Related Eye Disease Studies (AREDS and AREDS2) found that the progression of geographic atrophy (GA) in age-related macular degeneration is strongly linked to a decline in best-corrected visual acuity (BCVA) over 4 years. Read more: https://ow.ly/F8go50VcThF #GeographicAtrophy #AMD #VisualAcuity #MacularDegeneration

Looking for the latest research, clinical trials, and updates in the world of glaucoma? Visit our website's glaucoma topic center today! With expert-driven content and cutting-edge information, we’re your go-to destination for staying ahead in the field of glaucoma. Use the link below to check it out?? https://lnkd.in/eViBD5pn #WorldGlaucomaWeek #GlaucomaWeek #GlaucomaAwareness The Glaucoma Foundation

Kahook Dual Blade goniotomy with cataract surgery (phaco-KDB) surgery effectively lowers intraocular pressure (IOP) and reduces the need for glaucoma medications for up to three years, with better outcomes in patients who have not had prior laser trabeculoplasty (LTP) and those with pseudoexfoliative or pigmentary glaucoma, according to a poster presented at AGS 2025. View the article here: https://ow.ly/xGFk50VcSPV #AGS2025 #AmericanGlaucomaSociety #Goniotomy #Glaucoma

George Reiss, MD, of Eye Physicians & Surgeons of Arizona, discusses a study he presented at the 2025 American Glaucoma Society (AGS) Annual Meeting that compared use of iStent infinite versus Hydrus Microstent for glaucoma. Watch the complete video below ?? https://lnkd.in/e6a-Jxhs #Glaucoma #GlaucomaSurgery #MIGS

? NEW: FDA approves first treatment for MacTel. Read more ?? https://lnkd.in/eD6_3bYr Neurotech Pharmaceuticals, Inc.

The American Glaucoma Society 2025 Meeting recently wrapped up in Washington, DC. Ophthalmology 360 has you covered with all the latest news from the meeting. Check out the highlights from the meeting below. Hydrus microstent implantation does not impact refractive stability in cataract surgery: https://lnkd.in/eQM6qgat iStent infinite shows long-term effectiveness in managing glaucoma: https://lnkd.in/eUav5MgJ Co-management with optometrists helps reduce glaucoma specialist visits without compromising patient care: https://lnkd.in/eK3t5Gj9 Enhanced uveoscleral outflow with scleral allograft shows promising two-year results: https://lnkd.in/eq75QXq6 #Glaucoma #GlaucomaSpecialist #Cataracts